Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.35 |
| ▸ | BCHE | P06276 | 2/20 | 0.35 |
| ▸ | ACHE | P22303 | 2/20 | 0.35 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LTA4H | P09960 | 1/20 | 0.32 |
| ▸ | NQO1 | P15559 | 1/20 | 0.31 |
| ▸ | PTPRC | P08575 | 1/20 | 0.31 |
| ▸ | CDC25B | P30305 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL898540 | 0.77 | ESR1 (0.50) | L3MBTL1PTGS2BCHEACHETSHR | |
| SCHEMBL699772 | 0.77 | ALDH1A1 (0.38) | L3MBTL1PTGS2BCHEACHETSHR | |
| SCHEMBL5380106 | 0.75 | TSHR (0.55) | L3MBTL1PTGS2BCHEACHEPTPN2 | |
| SCHEMBL28002439 | 0.75 | L3MBTL1 (0.36) | L3MBTL1PTGS2BCHEACHETSHR | |
| SCHEMBL5393586 | 0.75 | ALDH1A1 (0.50) | L3MBTL1ALDH1A1PTPRC | |
| SCHEMBL8022572 | 0.75 | L3MBTL1 (0.43) | L3MBTL1ACHEALDH1A1 | |
| SCHEMBL933759 | 0.75 | IDO1 (0.39) | L3MBTL1PTGS2BCHEACHEPTPN2 | |
| SCHEMBL5397237 | 0.75 | CA1 (0.48) | L3MBTL1ACHETSHRALDH1A1 | |
| SCHEMBL29896649 | 0.75 | IDO1 (0.39) | L3MBTL1PTGS2BCHEACHEPTPN2 | |
| SCHEMBL6155730 | 0.75 | CASP1 (0.45) | L3MBTL1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0955304-B1 | Bridged metallocene complexes for the (co)polymerization of olefins | POLIMERI EUROPA SPA (IT) | 2003-09-03 | — | — | EP | disclosed |
| US-6417418-B2 | SUCH AS 1,3-PROPENYLIDENE-(1-INDENYL)2 ZIRCONIUM DICHLORIDE; HIGH ACTIVITY, MAKES HIGH MOLECULAR WEIGHT POLYMERS | ENICHEM S.P.A. (IT) | 2002-07-09 | — | — | US | disclosed |
| US-20010031885-A1 | Bridged metallocene complex for the (co) polymerization of olefins | ENICHEM S.P.A. (IT) | 2001-10-18 | — | — | US | disclosed |
| US-6211110-B1 | Bridged metallocene complex for the (co)polymerization of olefins | ENICHEM S.P.A. (IT) | 2001-04-03 | — | — | US | disclosed |
| EP-0955304-A2 | Bridged metallocene complex for the (co)polymerization of olefins | Enichem S.p.A. (IT) | 1999-11-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010031885-A1 | Bridged metallocene complex for the (co) polymerization of olefins | POF1B, MACF1, HAO2 | L3MBTL1 1678/4885PTGS2 2564/4885BCHE 162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.